Adalimumab 00074-1115
Product NDC
00074-1115- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 23, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 40 mg/.4mL |
Packaging Options(1)
.4 mL in 1 SYRINGE (0074-1115-00)